IL-6 Antikörper (AA 1-200)
Kurzübersicht für IL-6 Antikörper (AA 1-200) (ABIN7858570)
Target
Alle IL-6 (IL6) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-200
-
Verwendungszweck
- IL-6 (Interleukin-6) / Interferon beta-2 (Hybridoma Growth Factor) Antibody
-
Spezifität
- IL-6 is a potent lymphoid cell growth factor that stimulates the growth and survivability of certain B-cells and T-cells. It plays a critical role in B-cell differentiation to plasma cells and is a potent growth factor for plasmacytoma and myeloma. IL-6 is produced by a variety of cell types, including monocytes, fibroblasts and endothelial cells. Upon stimulation, macrophages, T, B, mast, and glial cells, eosinophils, keratinocytes and granulocytes also secrete IL-6.It is involved in host defense, acute phase reactions, immune responses, and hematopoiesis.
-
Aufreinigung
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant fragment (around aa1-200) of human IL-6 protein (exact sequence is proprietary)
-
Isotyp
- IgG2, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- IL-6 (IL6) (Interleukin 6 (IL6))
-
Andere Bezeichnung
- IL-6
-
Hintergrund
-
B-cell stimulatory factor 2 (BSF-2), CTL differentiation factor (CDF), Cytotoxic T cell differentiation factor, Hepatocyte stimulating factor (HSF), HPGF, Hybridoma growth factor Interferon beta-2, Hybridoma plasmacytoma growth factor, IFN-beta-2 (IFNB2)
Human heart or adrenal gland. Stimulated peritoneal macrophages.
-
Molekulargewicht
- 21kDa
-
Gen-ID
- 3569, 654458
-
UniProt
- P05231
-
Pathways
- TLR Signalweg, Hormone Transport, Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Regulation of Carbohydrate Metabolic Process, Autophagie, Cell RedoxHomeostasis, Cancer Immune Checkpoints, Inflammasome
Target
-